Lis Elisabeth Boyce

Immutep Limited | Non-Executive Director

Ms Boyce has over 30 years of experience including capital raising, strategic collaborations, corporate governance and mergers & acquisitions. She is a partner in Piper Aldermans corporate team, and cochairs the firms Life Sciences & Healthcare focus group. She has strong focus on Life Sciences is reflected in her appointment as deputy chair of AusBiotechs AusMedtech Advisory Group, and as Chair of AusBiotechs Leadership Committee for NSW. He is Member of the Risk Committee.

Company and Role

Company	Title	Tenure	Since
IMM Immutep Limited	Non-Executive Director	3yrs, 3mth	Apr 2023

Holding

Company	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
IMM Immutep Limited	02/12/25	423,288	N/A	N/A	N/A

Transactions

Company	Date	Type	Amount	Price	Value	Notes
IMM Immutep Limited	02/12/25	Issued	166,667	$0.280	$46,666	Conversion of securities
IMM Immutep Limited	02/12/25	Issued	707,232	$0.280	$198,024	Director remuneration
IMM Immutep Limited	02/12/25	Exercise	166,667	$0.280	$46,666	Conversion of securities
IMM Immutep Limited	06/12/24	Issued	256,621	$0.330	$84,684	Conversion of securities
IMM Immutep Limited	06/12/24	Exercise	256,621	$0.330	$84,684	Conversion of securities

Any feedback about this profile? Contact Us

Build your watchlist

Already have account? Log in